[Allogeneic hematopoietic stem cell transplantation for the treatment of BCR::ABL-negative neutrophilic myeloid neoplasms: a clinical analysis of 12 cases] [0.03%]
异基因造血干细胞移植治疗BCR::ABL阴性中性粒细胞白血病的临床分析（12例报告）
T T Han,Y He,J Liu et al.
T T Han et al.
Objective: To investigate the efficacy and safety of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for the treatment of BCR::ABL-negative chronic neutrophilic leukemia (CNL) and MDS/MPN with neutrophilia. Methods: This stud...
[Bendamustine combined with anti-CD20 monoclonal antibody in the first-line treatment of older patients with indolent B-cell non-Hodgkin lymphoma: a multicenter retrospective study] [0.03%]
苯达莫司汀联合抗CD20单克隆抗体治疗初治老年惰性B细胞非霍奇金淋巴瘤的疗效分析：多中心回顾性研究
S C Qin,Y Miao,Z L Zhang et al.
S C Qin et al.
Objective: To investigate the efficacy and safety of bendamustine combined with anti-CD20 monoclonal antibody in the first-line treatment of older patients with indolent B-cell non-Hodgkin lymphoma (B-iNHL) . Methods: The clinical data of 1...
[High-throughput sequencing in identifying somatic hypermutation in immunoglobulin heavy chain variable regions with complex clonal backgrounds] [0.03%]
高通量测序在免疫球蛋白重链可变区体细胞高频突变识别中的应用及挑战
M G Gao,R Wei,Y Liu et al.
M G Gao et al.
Objective: To compare the performance of next-generation sequencing (NGS) and Sanger sequencing in investigating somatic hypermutation (SHM) status of immunoglobulin heavy chain variable region (IGHV) genes. It specifically focuses on ident...
[Prognostic value of the FS-15 frailty score in patients with myelodysplastic syndromes] [0.03%]
FS-15衰弱评分在骨髓增生异常综合征患者中的预后价值
X Wang,T J Qin,Z F Xu et al.
X Wang et al.
Objective: To identify the prognostic value of the Revised 15-item Myelodysplastic Syndrome-specific frailty scale (FS-15) in Chinese patients with myelodysplastic syndromes (MDS) . Methods: This retrospective study analyzed 812 patients wi...
[Identify the factors associated with treatment-free remission outcomes after imatinib discontinuation in children and adolescent patients with chronic myeloid leukemia] [0.03%]
伊马替尼停药后儿童和青少年慢性髓性白血病治疗-free缓解的影响因素分析
H F Zhao,Q Jiang,W M Li et al.
H F Zhao et al.
Objective: To identify factors influencing treatment-free remission (TFR) outcomes in children and adolescent patients with chronic myeloid leukemia (CML) after imatinib (IM) discontinuation. Methods: This multicenter retrospective study an...
[Chinese expert consensus on the diagnosis and treatment of human immunodeficiency virus infection related diffuse large B cell lymphoma (2025)] [0.03%]
中国艾滋病相关弥漫性B细胞淋巴瘤诊断与治疗专家共识(2025)
Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association;Lymphoma Integrative Rehabilitation Professional Committee of Chinese Anti-Cancer Association (CACA);Central and Western Chi
Lymphoid Disease Group
Human immunodeficiency virus infection related diffuse large B cell lymphoma (HIV(+) DLBCL) exhibits a low incidence and a challenging diagnosis, with a lack of standardized treatment protocols. To improve the understanding of HIV(+) DLBCL ...
[Chinese expert consensus on the diagnosis and management of Epstein-Barr virus positive diffuse large B cell lymphoma (2025)] [0.03%]
中国阳性弥漫性大B细胞淋巴瘤诊断与治疗专家共识（2025）
Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association;Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO)
Lymphoid Disease Group
Epstein-Barr virus positive diffuse large B cell lymphoma (EBV(+) DLBCL) is a rare subtype of diffuse large B cell lymphoma with a poor prognosis. Due to the low incidence of EBV(+) DLBCL, the understanding of the disease has not been unifi...
[Research progress on targeted delivery of proteasome inhibitor nanoparticles for the treatment of multiple myeloma] [0.03%]
蛋白酶体抑制剂纳米粒靶向递送体系的研究进展及其治疗多发性骨髓瘤的作用机制探讨
Y X Lin,D H Jing,J Q Mi
Y X Lin
In recent years, proteasome inhibitors have been widely applied in the treatment of multiple myeloma (MM), demonstrating significant therapeutic value. However, these drugs face numerous clinical challenges, such as short circulation half-l...
[Strategies for the diagnosis and treatment of pulmonary chronic graft-versus-host disease after hematopoietic stem cell transplantation] [0.03%]
[造血干细胞移植后肺慢性移植物抗宿主病诊断和治疗策略]
C R Ju,S Q Wang,X Zhang et al.
C R Ju et al.
Hematopoietic stem cell transplantation (HSCT) is currently an effective method to cure hematologic malignancies and bone marrow failure diseases, and can restore hematopoietic function destroyed by hematologic malignant diseases. In recent...